Literature DB >> 8736403

Mitochondrial DNA depletion: prevalence in a pediatric population referred for neurologic evaluation.

C J Macmillan1, E A Shoubridge.   

Abstract

Mitochondrial DNA depletion is a quantitative disorder of mtDNA, characterized by tissue-specific reductions in mtDNA copy number, that presents in infancy or early childhood. It is most likely transmitted as an autosomal recessive trait, although about half of the described cases are sporadic. To estimate its prevalence we measured relative mtDNA copy number (mtDNA: 18S rDNA ratio) by Southern blot analysis in muscle biopsy samples from all children with compatible histories referred between 1983 and 1994. Of the 304 biopsies evaluated, 54 met the study criteria. We found 6 patients (2 male, 4 female) with mtDNA depletion (relative mtDNA copy number 7.9-33.2% of control). Their clinical course and findings were heterogeneous, however all but one manifested weakness, hypotonia, and developmental delay. Clinical severity was not obviously related to the degree of mtDNA depletion. No patient had ragged-red fibers, although 2 had a lipid storage myopathy. Immunofluorescence with antibodies to double-stranded DNA, COX IV, and COX II demonstrated homogeneously reduced reactivity to all three antibodies compared with control. mtDNA depletion may be a relatively common neurogenetic disorder of infancy and early childhood and should be considered in children with unexplained weakness, hypotonia, or developmental delay.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8736403     DOI: 10.1016/0887-8994(96)00018-5

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  10 in total

1.  Mitochondrial DNA depletion syndrome is expressed in amniotic fluid cell cultures.

Authors:  J C Blake; J W Taanman; A M Morris; R G Gray; J M Cooper; P J McKiernan; J V Leonard; A H Schapira
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 2.  Reversible infantile mitochondrial diseases.

Authors:  Veronika Boczonadi; Boglarka Bansagi; Rita Horvath
Journal:  J Inherit Metab Dis       Date:  2014-11-19       Impact factor: 4.982

Review 3.  Electron transport chain defects in heart failure.

Authors:  Jordi Casademont; Oscar Miró
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

4.  Infantile mitochondrial DNA depletion syndrome associated with methylmalonic aciduria and 3-methylcrotonyl-CoA and propionyl-CoA carboxylase deficiencies in two unrelated patients: a new phenotype of mtDNA depletion syndrome.

Authors:  S Yano; L Li; T P Le; K Moseley; A Guedalia; J Lee; I Gonzalez; R G Boles
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

5.  mtDNA depletion and impairment of mitochondrial function in a case of a multisystem disorder including severe myopathy.

Authors:  E J Kirches; K Winkler; M Warich-Kirches; R Szibor; F Wien; W S Kunz; P von Bossanyi; P K Bajaj; K Dietzmann
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 6.  Number matters: control of mammalian mitochondrial DNA copy number.

Authors:  Laura L Clay Montier; Janice J Deng; Yidong Bai
Journal:  J Genet Genomics       Date:  2009-03       Impact factor: 4.275

7.  Analysis of the Mitochondrial 4977 Bp Deletion in Patients with Hepatocellular Carcinoma.

Authors:  Z S Guo; C L Jin; Z J Yao; Y M Wang; B T Xu
Journal:  Balkan J Med Genet       Date:  2017-06-30       Impact factor: 0.519

Review 8.  Advances in Thymidine Kinase 2 Deficiency: Clinical Aspects, Translational Progress, and Emerging Therapies.

Authors:  Andres Berardo; Cristina Domínguez-González; Kristin Engelstad; Michio Hirano
Journal:  J Neuromuscul Dis       Date:  2022

9.  Clinicopathological Implications of Mitochondrial Genome Alterations in Pediatric Acute Myeloid Leukemia.

Authors:  Min-Gu Kang; Yu-Na Kim; Jun Hyung Lee; Michael Szardenings; Hee-Jo Baek; Hoon Kook; Hye-Ran Kim; Myung-Geun Shin
Journal:  Ann Lab Med       Date:  2016-03       Impact factor: 3.464

10.  Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy.

Authors:  Rita Horvath; John P Kemp; Helen A L Tuppen; Gavin Hudson; Anders Oldfors; Suely K N Marie; Ali-Reza Moslemi; Serenella Servidei; Elisabeth Holme; Sara Shanske; Gittan Kollberg; Parul Jayakar; Angela Pyle; Harold M Marks; Elke Holinski-Feder; Mena Scavina; Maggie C Walter; Jorida Coku; Andrea Günther-Scholz; Paul M Smith; Robert McFarland; Zofia M A Chrzanowska-Lightowlers; Robert N Lightowlers; Michio Hirano; Hanns Lochmüller; Robert W Taylor; Patrick F Chinnery; Mar Tulinius; Salvatore DiMauro
Journal:  Brain       Date:  2009-08-31       Impact factor: 13.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.